Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 21 | 21 | 171 | 21 | 0 |
| Gross Profit | 21 | 21 | 171 | 21 | N/A |
| Operating Expenses | 19,765 | 16,469 | 13,883 | 12,169 | 9,321 |
| Operating Income | -19,744 | -16,448 | -13,712 | -12,148 | -9,321 |
| Other Income | 20 | 17 | 18 | 2 | 0 |
| Pre-tax Income | -19,724 | -16,431 | -13,694 | -12,146 | -9,321 |
| Net Income Continuous | -19,724 | -16,431 | -13,694 | -12,146 | -9,321 |
| Net Income | $-19,724 | $-16,431 | $-13,694 | $-12,146 | $-9,321 |
| EPS Basic Total Ops | -9.15 | -8.25 | -6.90 | 51.72 | -54.87 |
| EPS Basic Continuous Ops | -9.08 | -8.31 | -6.93 | 51.66 | -54.91 |
| EPS Diluted Total Ops | -9.15 | -8.25 | -6.90 | 51.72 | -54.87 |
| EPS Diluted Continuous Ops | -9.08 | -8.31 | -6.93 | 51.66 | -54.91 |
| EBITDA(a) | $-19,638 | $-16,406 | $-13,669 | $-12,110 | $-9,284 |